Complete Genomics ETF Forecast

Sell candidate since Jul 27, 2026 Gain 0.06%

The Complete Genomics, Inc ETF price fell by -0.333% on the last day (Wednesday, 29th Jul 2026) from $53.90 to $53.72. During the last trading day the ETF fluctuated 1.93% from a day low at $53.43 to a day high of $54.46. The price has fallen in 7 of the last 10 days and is down by -4.06% for this period. Volume has increased on the last day by 8 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 16 thousand shares were bought and sold for approximately $876.30 thousand.

Given the current short-term trend, the ETF is expected to rise 26.73% during the next 3 months and, with a 90% probability hold a price between $68.08 and $79.21 at the end of this 3-month period.

GNOM Signals & Forecast

There are few to no technical positive signals at the moment. The Complete Genomics, Inc ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the ETF. On corrections up, there will be some resistance from the lines at $54.25 and $54.23. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -8.68%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Complete Genomics, Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Complete Genomics, Inc ETF

Complete Genomics, Inc finds support from accumulated volume at $52.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $1.03 between high and low, or 1.93%. For the last week, the ETF has had daily average volatility of 1.62%.

Complete Genomics, Inc is oversold on RSI14 (23). Some ETFS may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GNOM) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect Complete Genomics, Inc to open at $53.87, and during the day (based on 14 day Average True Range), to move between $53.10 and $54.34, which gives a possible trading interval of +/-$1.24 (+/-2.34%) up or down from last closing price. If Complete Genomics, Inc takes out the full calculated possible swing range there will be an estimated 2.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $54.96 (2.31%) than the support at $52.23 (2.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Complete Genomics, Inc ETF A Buy?

The Complete Genomics, Inc ETF holds several negative signals and despite the positive trend, we believe Complete Genomics, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this ETF.

Current score: -4.876 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $53.87 ( 0.278%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk